Yubo International Biotech Stock EBITDA
| YBGJ Stock | USD 0.07 0.0001 0.15% |
Yubo International Biotech fundamentals help investors to digest information that contributes to Yubo International's financial success or failures. It also enables traders to predict the movement of Yubo Pink Sheet. The fundamental analysis module provides a way to measure Yubo International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Yubo International pink sheet.
Yubo |
Yubo International Biotech Company EBITDA Analysis
Yubo International's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Yubo International EBITDA | (1.54 B) |
Most of Yubo International's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yubo International Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Yubo International Biotech reported earnings before interest,tax, depreciation and amortization of (1.54 Billion). This is 275.74% lower than that of the Healthcare sector and significantly lower than that of the Medical Instruments & Supplies industry. The ebitda for all United States stocks is 139.55% higher than that of the company.
Yubo EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Yubo International's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Yubo International could also be used in its relative valuation, which is a method of valuing Yubo International by comparing valuation metrics of similar companies.Yubo International is currently under evaluation in ebitda category among its peers.
Yubo Fundamentals
| Return On Equity | -20.23 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (4.59) % | |||
| Current Valuation | 14.08 M | |||
| Shares Outstanding | 119.82 M | |||
| Shares Owned By Insiders | 95.45 % | |||
| Price To Book | 61.23 X | |||
| Price To Sales | 26.55 X | |||
| Revenue | 1.24 B | |||
| Gross Profit | 820.65 K | |||
| EBITDA | (1.54 B) | |||
| Net Income | (1.54 B) | |||
| Cash And Equivalents | 36.58 K | |||
| Total Debt | 2.4 M | |||
| Current Ratio | 0.25 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.02 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 20 | |||
| Beta | -2.88 | |||
| Market Capitalization | 10.54 M | |||
| Total Asset | 4.59 K | |||
| Net Asset | 4.59 K |
About Yubo International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Yubo International Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yubo International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yubo International Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Yubo Pink Sheet
Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.